Influence of CReatine Supplementation on mUScle Mass and Strength After Stroke (ICaRUS Stroke Trial): A Randomized Controlled Trial
Nutrients · 2024
DOI: 10.3390/nu16234148 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2024. Verfasst von Juli T Souza und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Medical School, São Paulo State University (UNESP), Botucatu 18618-970, SP, Brazil. Hauptthemen laut MEDLINE: Creatine, Dietary Supplements, Muscle Strength, Stroke. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Voucher for Special Issue, National Council for Scientific and Technological Development (CNPq), Coordination for the Improvement of Higher Education Personnel (CAPES)—001.
Themen: Schlaganfall
Abstract (Originalsprache)
Background/Objectives: The acute phase of stroke is marked by inflammation and mobility changes that can compromise nutritional status. This study was a randomized, double-blind, placebo-controlled trial evaluating the effectiveness of creatine supplementation for older people during seven days of hospitalization for stroke compared to usual care.
Method
The primary outcome measures were changes in functional capacity, strength, muscle mass, and muscle degradation. The secondary outcomes were changes in serum biomarkers related to inflammation, fibrosis, anabolism, and muscle synthesis. In addition, a follow-up 90 days after the stroke verified functional capacity, strength, quality of life, and mortality. Following admission for an acute stroke, participants received either creatine (10 g) or a visually identical placebo (10 g) orally twice daily. Both groups received supplementation with protein to achieve the goal of 1.5 g of protein/kg of body weight/day and underwent daily mobility training during seven days of hospitalization.
Results
Thirty older people were included in two similar groups concerning baseline attributes (15—treatment/15—placebo).
Conclusions
Creatine supplementation did not influence functional capacity, strength, or muscle mass during the first 7 days or outcomes 90 days after stroke. There were no serious adverse events associated with creatine supplementation. However, it decreased progranulin levels, raising a new possibility of creatine action. This finding needs further exploration to understand the biological significance of creatine–progranulin interaction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Medical School, São Paulo State University (UNESP), Botucatu 18618-970, SP, Brazil.
- Department of Neuroscience and Mental Health, Medical School, São Paulo State University (UNESP), Botucatu 18618-970, SP, Brazil.
- MRC-Versus Arthritis Centre for Musculoskeletal Ageing Research (CMAR) & NIHR Nottingham Biomedical Research Centre, University of Nottingham Medical School, Derby Uttoxeter Road, Derby DE22 3DT, UK.
- Wolfson Institute of Public Health, Queen Mary University of London, London E1 4NS, UK.
- Academic Centre for Healthy Ageing, Whipps Cross Hospital, Barts Health NHS Trust, London E1 1BB, UK.
- Stable Isotopes Center, São Paulo State University (UNESP), Institute of Biosciences, Botucatu 18618-970, SP, Brazil.
ORCID-Profile: Juli T Souza, Bertha F Polegato, Marina P Okoshi, Philip J Atherton, Kenneth Smith, Adam L Gordon, Suzana E Tanni, Vladimir E Costa, Rodrigo Bazan, Paula S Azevedo
Förderung
- Voucher for Special Issue
- National Council for Scientific and Technological Development (CNPq)
- Coordination for the Improvement of Higher Education Personnel (CAPES)—001
- CAPES—001–Notice 02
Zitieren
APA
Souza, J. T., Minicucci, M. F., Ferreira, N. C., Polegato, B. F., Okoshi, M. P., Modolo, G. P., Leal-Pereira, F. W., Phillips, B. E., Atherton, P. J., Smith, K., Wilkinson, D. J., Gordon, A. L., Tanni, S. E., Costa, V. E., Fernandes, M. F., Bazan, S. G., Zornoff, L. M., Paiva, S. R., Bazan, R., & Azevedo, P. S. (2024). Influence of CReatine Supplementation on mUScle Mass and Strength After Stroke (ICaRUS Stroke Trial): A Randomized Controlled Trial. Nutrients. https://doi.org/10.3390/nu16234148
Vancouver
Souza JT, Minicucci MF, Ferreira NC, Polegato BF, Okoshi MP, Modolo GP, et al. Influence of CReatine Supplementation on mUScle Mass and Strength After Stroke (ICaRUS Stroke Trial): A Randomized Controlled Trial. Nutrients. 2024. doi:10.3390/nu16234148
BibTeX
@article{Souza2024,
author = {Souza, Juli T and Minicucci, Marcos F and Ferreira, Natália C and Polegato, Bertha F and Okoshi, Marina P and Modolo, Gabriel P and Leal-Pereira, Filipe W and Phillips, Bethan E and Atherton, Philip J and Smith, Kenneth and Wilkinson, Daniel J and Gordon, Adam L and Tanni, Suzana E and Costa, Vladimir E and Fernandes, Maria F and Bazan, Silméia G and Zornoff, Leonardo M and Paiva, Sérgio R and Bazan, Rodrigo and Azevedo, Paula S},
title = {Influence of CReatine Supplementation on mUScle Mass and Strength After Stroke (ICaRUS Stroke Trial): A Randomized Controlled Trial},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16234148}
}
EUVIMED